登录 注册 会员服务 联系我们

Radioresponsive Delivery of Toll-like Receptor 7/8 Agonist for Tumor Radioimmunotherapy Enabled by Core-Cross-Linked Diselenide Nanoparticles

  • Published:2024-01-16 Issue:4 Volume:18 Page:2800-2814
  • ISSN:1936-0851
  • Container-title:ACS Nano
  • language:en
  • Short-container-title:ACS Nano

Author:

Wu Yanxian1,Qin Jianzhong2,Gu Yuan1,Zhao Gang1,Xu Pei1,Lin Subin2,Cheng Xiaju1,Zhang Leshuai W.1ORCID,Wang Yangyun1,Wang Yong1ORCID

Affiliation:

1. State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China

2. Department of Orthopedic, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou 215004, China

Funder

China National Nuclear Corporation

Soochow University

Natural Science Foundation of Jiangsu Province

State Key Laboratory of Radiation Medicine and Protection

National Natural Science Foundation of China

Priority Academic Program Development of Jiangsu Higher Education Institutions

Tang Scholar Program

State Key Laboratory of Biotherapy

Publisher

American Chemical Society (ACS)

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3